Wall Street analyst estimates for Concord Medical Services Holdings Limited (CCM): consensus price target, buy/hold/sell recommendations and forecasts for revenue, EPS and EBITDA for the upcoming fiscal years.
Concord Medical Services Holdings Limited, through its subsidiaries, operates a network of radiotherapy and diagnostic imaging centers in the People’s Republic of China. It operates in two segments, Network and Hospital. The company’s services include linear accelerators and external beam radiotherapy, proton therapy system, gamma knife radiosurgery, and diagnostic imaging services.
Recent Earnings Surprises
| Date | EPS Actual | EPS Est. | vs Est. |
|---|---|---|---|
| 2026-09-25 | |||
| 2026-03-31 | |||
| 2025-04-25 | $-12.81 | ||
| 2024-12-25 | $-0.64 | ||
| 2024-10-28 | $-0.67 | ||
| 2024-04-19 | $-0.82 | ||
| 2024-03-26 | $-1.00 | ||
| 2023-09-22 | $-0.97 |
Income Statement (10y)
| Year | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $455.0M | $331.0M | $190.9M | $198.4M | $223.0M | $485.6M | $472.1M | $537.4M | $384.0M | $460.5M |
| Cost of Revenue | $286.5M | $233.0M | $171.1M | $214.2M | $209.9M | $542.5M | $624.5M | $614.0M | $463.1M | $434.7M |
| Gross Profit | $168.5M | $98.0M | $19.8M | -$15.8M | $13.1M | -$56.9M | -$152.4M | -$76.6M | -$79.2M | $25.8M |
| Research & Development | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Selling, General & Admin | $276.0M | $281.3M | $313.6M | $345.4M | $320.6M | $401.4M | $372.6M | $386.4M | $453.0M | $265.2M |
| Operating Expenses | $337.1M | $309.9M | $319.0M | $421.5M | $329.1M | $401.4M | $372.6M | $386.4M | $453.0M | $265.2M |
| Operating Income | -$168.6M | -$211.9M | -$299.2M | -$437.3M | -$316.0M | -$458.3M | -$525.0M | -$463.0M | -$532.2M | -$239.3M |
| EBITDA | $20.3M | -$93.8M | -$248.8M | -$304.9M | -$236.7M | -$363.9M | -$401.9M | -$344.2M | -$345.6M | -$71.8M |
| Interest Expense | $89.3M | $90.0M | $46.2M | $28.7M | $81.4M | $73.8M | $120.4M | $165.7M | $193.2M | $152.3M |
| Pre-tax Income | -$204.6M | -$253.9M | -$225.2M | -$391.1M | -$441.7M | -$529.2M | -$839.9M | -$555.6M | -$669.6M | -$373.4M |
| Income Tax | $60.5M | $31.8M | $34.1M | -$39.0M | -$37.6M | -$6.6M | -$70.9M | -$24.6M | -$17.5M | $6.1M |
| Net Income | -$261.9M | -$284.3M | -$234.9M | -$307.0M | -$310.0M | -$271.4M | -$489.7M | -$297.7M | -$308.2M | -$92.8M |
| EPS | $-1804.20 | $-1967.10 | $-2484.90 | $-3818.10 | $-6987.00 | $-5635.50 | $-3362.70 | $-2044.20 | $-2116.80 | $-621.00 |
| EPS (Diluted) | $-1804.20 | $-1967.10 | $-2484.90 | $-3818.10 | $-4600.50 | $-5635.50 | $-3362.70 | $-2044.20 | $-2116.80 | $-621.00 |
| Shares Outstanding (Diluted) | $145133 | $144533 | $144566 | $144700 | $145600 | $145600 | $145600 | $145600 | $145600 | $145615 |
Price
| Price | $3.92 |
| Market Cap | $1M |
| Exchange | NYSE |
| Country | CN |
Related companies: ADTX · BACK · CELU · HEPA · IVF · PTPI · SISI
Explore sector: Healthcare · Medical - Care Facilities
More sections of CCM: Overview · Financials · Valuation · Statistics · Technical · Ownership · News · Events
Discover more: Radar — undervalued stock signals · Investment Academy — learn to analyze stocks